Helvetia Group:企業の戦略・SWOT・財務情報

◆英語タイトル:Helvetia Group - Strategy, SWOT and Corporate Finance Report
◆商品コード:DATA904C6194
◆発行会社(調査会社):MarketLine
◆発行日:2018年10月
◆ページ数:21
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:スイス
◆産業分野:サービス
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD175 ⇒換算¥25,900見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD525 ⇒換算¥77,700見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

Helvetia Group – Strategy, SWOT and Corporate Finance Report
Summary

Helvetia Group – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Helvetia Group (Helvetia) is a multi-line insurance provider. The group offers a wide range of life and non-life insurance and reinsurance products. It offers traditional individual life insurance, group insurance, investment-linked life insurance, and individual life insurance. It also offers insurance products for property, motor vehicle, liability, accident and health, travel, transport, art, and engineering. It also offers customized specialty lines coverage and reinsurance products. The group’s products and services are distributed through its own sales force, direct sales, insurance brokers, partners and agents. It serves retail customers, small and medium-sized businesses and corporates. The group operates through branch offices and subsidiaries in Switzerland, Germany, Austria, Spain, Italy and France. Helvetia is headquartered in St Gallen, Switzerland.

The group reported gross premiums written of CHF8,478.1 million for the fiscal year ended December 2017 (FY2017), which indicates an increase of 0.9% over that in FY2016. Its net premiums written were CHF8,102.6 million in FY2017, which shows an increase of 0.2% over that in FY2016.

Scope

- Detailed information on Helvetia Group required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Helvetia Group in the form of a SWOT analysis
- An in-depth view of the business model of Helvetia Group including a breakdown and examination of key business segments
- Intelligence on Helvetia Group’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Helvetia Group, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Helvetia Group and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Helvetia Group as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Helvetia Group’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot 2
Table of Contents 4
Helvetia Group: Company Overview 7
Helvetia Group: Overview and Key Facts 7
Helvetia Group: Overview 7
Helvetia Group: Key Facts 7
Helvetia Group: Locations and Subsidiaries 8
Helvetia Group: Corporate Financial Deals Activity 9
Helvetia Group: Financial Deals Overview 9
Helvetia Group: Targets and Partners 11
Helvetia Group: Top Deals 2014 – 2018YTD* 12
Helvetia Group: Advisors 13
Helvetia Group: Top Legal Advisors 13
Helvetia Group: Mergers and Acquisitions 14
Helvetia Group: Corporate Venturing 15
Helvetia Group: Recent Developments 16
Helvetia Group: News and Events Summary 16
Helvetia Group: Corporate Governance 16
Helvetia Group: Financial Deals 17
Helvetia Group: Financial Performance 17
Appendix 19
Contact Us 19
Methodology 19
About MarketLine 20

List of Tables
Table 1: Helvetia Group: Key Facts
Table 2: Helvetia Group: Locations and Subsidiaries
Table 3: Helvetia Group: Deal Activity by Deal Type - Volume (TTM*)
Table 4: Helvetia Group: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Table 5: Helvetia Group: M&A Average Deal Size - Value (US$m)
Table 6: Helvetia Group: Targets and Partners
Table 7: Helvetia Group: Top Deals 2014 - 2018YTD*
Table 8: Helvetia Group: Legal Advisor Ranking by Value (US$m)
Table 9: Helvetia Group: M&A Volume and Value Trend (2014 - YTD*2018)
Table 10: Helvetia Group: M&A Activity by Geography (2014 - YTD*2018)
Table 11: Helvetia Group: Corporate Venturing Volume and Value Trend (2014 - YTD*2018)
Table 12: Helvetia Group: Corporate Venturing by Geography (2014 - YTD*2018)
Table 13: Helvetia Group: News and Events Summary
Table 14: Helvetia Group: Corporate Governance
Table 15: Helvetia Group: Financial Deals
Table 16: Helvetia Group: Financial Performance

List of Figures
Figure 1: Helvetia Group: Deal Activity by Deal Type - Volume (TTM*)
Figure 2: Helvetia Group: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Figure 3: Helvetia Group: M&A Average Deal Size - Value (US$m)
Figure 4: Helvetia Group: M&A Volume and Value Trend (2014 - YTD*2018)
Figure 5: Helvetia Group: M&A Activity by Geography (2014 - YTD*2018)
Figure 6: Helvetia Group: Corporate Venturing Volume and Value Trend (2014 - YTD*2018)
Figure 7: Helvetia Group: Corporate Venturing by Geography (2014 - YTD*2018)

★海外企業調査レポート[Helvetia Group:企業の戦略・SWOT・財務情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Cantex Mine Development Corp (CD):企業の財務・戦略的SWOT分析
    Summary Cantex Mine Development Corp (Cantex) is a mining and mineral exploration company. The company’s business activities include acquisition, exploration, and development of cobalt, copper, manganese, zinc, gold, nickel, and platinum properties. Its projects comprise Al Hariqah Gold project, Al …
  • Akorn Inc (AKRX):製薬・医療:M&Aディール及び事業提携情報
    Summary Akorn Inc (Akorn) develops, manufactures, and commercializes generic and branded prescription pharmaceuticals and branded and over-the-counter consumer health products and animal health pharmaceuticals. The company offers its products in both sterile and non-sterile dosage forms including or …
  • Scotiabank Peru S.A.A.
    Scotiabank Peru S.A.A. - Strategy, SWOT and Corporate Finance Report Summary Scotiabank Peru S.A.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • PH&T SpA-製薬・医療分野:企業M&A・提携分析
    Summary PH&T SpA (PH&T), a subsidiary of Wise SGR SpA is a pharmaceutical company that conducts research activities. The company carries out research, development and manufacturing of generic drugs for specialist therapies, medical devices and nutraceuticals. It provides difficult to formulate presc …
  • Swarovski AG:企業の戦略・SWOT・財務情報
    Swarovski AG - Strategy, SWOT and Corporate Finance Report Summary Swarovski AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Sa Sa International Holdings Limited (178):企業の財務・戦略的SWOT分析
    Sa Sa International Holdings Limited (178) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengt …
  • Massmart Holdings Limited (MSM):企業の財務・戦略的SWOT分析
    Massmart Holdings Limited (MSM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Postal Savings Bank of China Co., Ltd. (1658):企業の財務・戦略的SWOT分析
    Postal Savings Bank of China Co., Ltd. (1658) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key stre …
  • Lanxess AG:企業の戦略・SWOT・財務情報
    Lanxess AG - Strategy, SWOT and Corporate Finance Report Summary Lanxess AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Columbia Banking System Inc:企業の戦略・SWOT・財務情報
    Columbia Banking System Inc - Strategy, SWOT and Corporate Finance Report Summary Columbia Banking System Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Ambry Genetics Corp:医療機器:M&Aディール及び事業提携情報
    Summary Ambry Genetics Corp (Ambry Genetics), a subsidiary of Konica Minolta Inc, is a provider of clinical genetic testing services. The company provides genetic diagnosis for various conditions including hereditary cancer, epilepsy, hereditary cardiovascular disease and neurodevelopmental disorder …
  • Medical College of Wisconsin-医療機器分野:企業M&A・提携分析
    Summary Medical College of Wisconsin (MCW) is a medical educational institution that offers biomedical education, patient care and research services. The college provides medical courses in the fields of biomedical sciences, post-doctoral education, patient and public health. It offers these courses …
  • Revance Therapeutics Inc (RVNC)-製薬・医療分野:企業M&A・提携分析
    Summary Revance Therapeutics Inc (Revance Therapeutics) develops, manufactures and commercializes novel botulinum toxin products. The company’s product candidate includes RT002, an injectable formulation of botulinum toxin type for the treatment of glabellar lines, cervical dystonia, and plantar fas …
  • InvitroCue Ltd (IVQ):企業の財務・戦略的SWOT分析
    Summary InvitroCue Ltd (InvitroCue), formerly Bunuru Corporation Ltd, is a provider of bio-analytic solutions. The company provides digital pathology services such as digitization, sample preparation, staining, computer aided diagnosis and consultation, telepathology, automated reporting and image a …
  • AstraZeneca Plc (AZN)-製薬・医療分野:企業M&A・提携分析
    Summary AstraZeneca plc (AstraZeneca) is a biopharmaceutical company that endeavors to discover, produce and commercialize a wide range of prescription drugs. It focuses on therapy areas such as respiratory; cardiovascular and metabolic disease (CVMD); and cancer, besides autoimmune, infection and n …
  • Abu Dhabi National Energy Co (TAQA):企業の財務・戦略的SWOT分析
    Abu Dhabi National Energy Co (TAQA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Culp Inc (CULP):企業の財務・戦略的SWOT分析
    Culp Inc (CULP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Actinium Pharmaceuticals Inc (ATNM):企業の財務・戦略的SWOT分析
    Summary Actinium Pharmaceuticals Inc (Actinium), formerly Cactus Ventures Inc, is a biopharmaceutical company. It develops antibody radiation conjugates (ARC), which combine the targeting ability of antibodies with the cell killing ability of radiation. The company's pipeline products include Iomab- …
  • Virbac Corporation
    Virbac Corporation - Strategy, SWOT and Corporate Finance Report Summary Virbac Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Best Western International Inc:企業の戦略・SWOT・財務情報
    Best Western International Inc - Strategy, SWOT and Corporate Finance Report Summary Best Western International Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆